CHIMERA INVESTMENT CORP (CIM) Stock Analyst Ratings
USA - NYSE:CIM - US16934Q8024 - REIT
13.99 USD
-0.05 (-0.36%)
13.99 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 73% to CIM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.81. This target is 13.01% above the current price.
CIM was analyzed by 8 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CIM.
In the previous month the buy percentage consensus was at a similar level.
CIM was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-10 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-07-10 | UBS | Maintains | Buy -> Buy |
| 2025-05-14 | UBS | Upgrade | Neutral -> Buy |
| 2025-01-23 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-08-08 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-07-10 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2023-12-06 | UBS | Initiate | Neutral |
| 2023-05-19 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-05-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-05-09 | Keefe, Bruyette & Woods | Maintains | Market Perform |
| 2023-04-24 | Keefe, Bruyette & Woods | Maintains | Market Perform |
| 2023-03-09 | Credit Suisse | Reiterate | Neutral |
| 2023-03-07 | RBC Capital | Reiterate | Outperform |
| 2022-10-05 | RBC Capital | Maintains | Outperform |
| 2022-07-18 | Barclays | Maintains | Underweight |
| 2022-05-23 | RBC Capital | Maintains | Outperform |
| 2022-04-27 | Barclays | Maintains | Underweight |
| 2022-01-10 | Barclays | Maintains | Underweight |